Tageos and Wiliot Partner to Accelerate Ambient IoT, Battery-Free BLE Sensing
22.1.2026 16:07:00 CET | Business Wire | Press Release
Tageos, a global leader in RFID and wireless IoT inlays and tags, today announced a strategic partnership with ambient IoT pioneer Wiliot. The first outcome of this collaboration is the launch of a new passive Bluetooth® Low Energy (BLE) inlay, the EOS-654 BLE G3. In response growing demand for real-time location and condition monitoring across retail and logistics supply chains, this inlay was developed to support large-scale deployment of Wiliot’s Gen3 IoT Pixel sensor and the Wiliot Intelligence Platform.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260122940104/en/
The new EOS-654 BLE G3 features a dual-band architecture operating at 2.4 GHz and sub-1 GHz. This inlay design enables longer-range energizing, more reliable broadcasts, and greater performance consistency across environments such as distribution centers, trailers, retail backrooms, and store floors. Delivered as a dry inlay, it is ready for conversion into Wiliot’s Gen3 IoT Pixel sensor.
Requiring no batteries, the Gen3 IoT Pixel sensor works with cost-effective Bluetooth reader infrastructure to transmit item-level data to the Wiliot Intelligence Platform. The platform analyzes continuous streams of location, temperature, humidity, light, dwell time, and movement data to power physical AI solutions, including cycle counting, shipment verification, reusable asset tracking, and condition monitoring.
The EOS-654 BLE G3 inlay was developed in cooperation with Wiliot at Tageos’ Innovation Center of Excellence (ICoE), which opened in Munich, Germany, in April 2025 in response to increasing demand for cutting-edge wireless technologies. Specializing in product innovations such as advanced antenna design, battery-free and battery-powered BLE sensors, and multi-component integration into roll-to-roll inlay manufacturing, the ICoE is part of the company’s comprehensive research and development organization. Once final product development and validation are complete, products can be seamlessly industrialized within Tageos’ global manufacturing network, which currently has a total production capacity of 12 billion units per year across locations in France, the United States, and China.
“We are proud to work with a global, high-capacity inlay manufacturer to further secure supply for the growing demand for our battery-free Gen3 IoT Pixel BLE sensors,” said Amir Khoshniyati, VP Marketing and Business Development at Wiliot. “Combined with the Wiliot Intelligence Platform, this partnership powers the data layer behind physical AI and redefines real-time visibility across modern supply chains. Tageos’ innovation capabilities and proven ability to scale to billions of units make them an ideal partner for our rapid growth in ambient IoT.”
“With Tageos’ innovation and commitment to quality, in addition to our expertise in inlay manufacturing, combined with our capacity we are taking another significant step towards ambient IoT performance and battery-free BLE sensing technology,” said Hector Gomez, VP of Specialty Products at Tageos. “Wiliot shares our commitment to pioneering ideas and actions, and we are excited to expand our partnership further to unlock new applications and drive ongoing growth for the benefit of our customers worldwide.”
###
About Tageos
Tageos® is a global market leader in the design and manufacturing of RFID and wireless IoT inlays and tags. We provide a comprehensive portfolio of high-quality, innovative products and sensors (RAIN RFID/UHF, NFC/HF, BLE), enabling end-customers such as retailers, brand owners, and industrial manufacturers to identify, authenticate, track, and trace a wide range of products and assets. Tageos is ISO 9001:2015 and ISO 14001:2015 certified and holds ARC Quality Certification from Auburn University’s RFID Lab. Headquartered in Montpellier, France, Tageos operates manufacturing sites and offices in France, USA, China, Germany, Hong Kong (SAR), Italy, and Mexico.
About Wiliot
Wiliot, a pioneer of Ambient IoT, powers your supply chain with continuous, scan-free visibility into item location and condition. The Wiliot Intelligence Platform processes signals from battery-free Bluetooth sensors (IoT Pixels) in the Wiliot Cloud using purpose-built AI and ML models. This enables real-time automated condition monitoring, inventory intelligence, and workflow optimization. Whether you have AI in place or are just starting, Wiliot delivers continuous, AI-ready data that drives ROI today and scales into advanced AI tomorrow.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260122940104/en/
Contacts
Media Inquiries:
Geoffrey Riggs
Global Communications Manager
communications@tageos.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom